Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-10-07
1995-02-14
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548251, 548252, 548253, 5483034, 548112, 514393, 514 91, C07D48704, C07D48702, A61K 3141, A61K 31415
Patent
active
053896602
ABSTRACT:
There are disclosed new substituted imidazo-fused 5-membered ring heterocyclic compounds and derivatives thereof which are useful as angiotensin II antagonists. These compounds have the general formula: ##STR1##
REFERENCES:
J. of Parma. & Experimental Therapeutics, vol. 262, No. 1, (1992), By R. S. L. Chang, et al.
Chiu et al., Eur. J. Pharm. Exp. Ther., 157, 13-21 (1988).
Wong et al, J. Pharm. Exp. Ther., 247, 1-7 (1988).
Chakravarty Prasun K.
Greenlee William J.
Johnston David B. R.
Maccoss Malcolm
Mantlo Nathan B.
DiPrima Joseph F.
Merck & Co. , Inc.
North Robert J.
Springer David B.
LandOfFree
Substituted imidazo-fused 5-membered ring heterocycles as angiot does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazo-fused 5-membered ring heterocycles as angiot, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazo-fused 5-membered ring heterocycles as angiot will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-288474